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1.1. Inhibitors of the serine protease plasmin
Proteases regulate many physiological processes includ-
ing growth, cellular migration and remodelling of the
extracellular matrix (ECM). Within the protease family
exists plasmin, a serine protease that plays a key role
during ECM remodelling by degrading matrix compo-
nents such as ﬁbrin, ﬁbronectin, laminin and proteogly-
cans. In addition to its direct role, plasmin also plays an
indirect role by activating the matrix metalloproteases
(MMPs) MMP-1, 3, and 9. These MMPs in turn regu-
late matrix deposition and remodelling.
Recently, a number of studies have shown that ECM
remodelling is one of the key processes associated with
angiogenesis, tumour growth, and invasion. Thus potent
and selective inhibitors of plasmin may have potential as
chemotherapeutic agents that impede angiogenesis and
block the rapid growth of primary tumours, as well as
the spread of secondary metastases. Recent work has
disclosed the generation of a library of putative inhibi-
tors with the general structure (i).1
This library of 400 compounds, synthesised in mixtures
of 20, was prepared on Wang resin solid support. Com-
pounds were screened against the serine protease plas-
min which identiﬁed a number of active mixtures.
Following a deconvolution procedure, a number of
active compounds, now prepared and screened as single-
tons, were discovered. One of the most potent inhibitors
of plasmin was (ii) which possessed an IC50 of 2.7 lM.
The speciﬁcity of (ii) was determined against three other
trypsin-like serine proteases (kallikrein, thrombin and
trypsin). At a concentration of 400 lM against these
enzymes, no inhibition was observed, indicating (ii)doi:10.1016/j.comche.2006.02.001
E-mail: nick.terrett@pﬁzer.compossessed at least 150-fold selectivity for plasmin over
these other proteases. Given that compounds in the ser-
ies typiﬁed by (i) are high molecular weight, peptide-like
compounds, it is unlikely they will have good oral bio-
availability. One way to improve their pharmacokinetic
characteristics would be to replace the amide bonds by
appropriate non-hydrolysable analogues.1.2. Inhibitors of subgenomic hepatitis C virus RNA
replication
The hepatitis C virus (HCV) has been identiﬁed as the
pathogen responsible for most cases of non-A and
non-B hepatitis. HCV infection is a major worldwide
health problem with around 170 million carriers of the
virus globally. HCV can lead to life-threatening liver dis-
orders such as cirrhosis and is now recognized as the sin-
gle largest cause of liver transplantation. New therapies
to tackle HCV are urgently required but eﬀorts toward
them have been impeded by the fact HCV is not
infectious in cell culture, or in small animal models.
The recent introduction of the HCV replicon assay as
a surrogate cell-based system in which replication of
subgenomic viral RNA is studied, has provided
assistance for drug discovery eﬀorts targeting HCV
proteins.
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protease, show potency in this system and also elicit a
strong reduction in viral titre in a clinical setting. In
addition to NS3, the non-structural region of the HCV
genome encodes several additional enzymes that are
believed to play important roles in the viral life cycle,
and are thus viable targets for drug discovery. The
NS5B protein is one such target and has been character-
ised as the RNA polymerase enzyme that catalyses the
synthesis of both a complementary ()-stranded HCV
RNA intermediate and the (+)-stranded viral genome
itself. NS5B has emerged as an attractive target for drug
discovery eﬀorts towards treatment of HCV, and has
been described as the most drugable HCV protein.
Towards the goal of new HCV therapeutics, several
series of NS5B inhibitors that show activity in the
replicon assay have been reported. However, to date
no non-nucleoside inhibitors that both bind at the active
site of NS5B and show cell based activity have been
reported. However, allosteric inhibition by small-mole-
cule inhibitors of NS5B have emerged as one potential
route for inhibition of subgenomic HCV RNA replica-
tion, and a number of structurally diverse inhibitor
classes have been identiﬁed. Recent work has been
disclosed that has sought to optimise a series of com-
pounds that show encouraging inhibition against the
NS5B enzyme.2
Promising activity in a replicon assay has been observed
with compounds typiﬁed by (iii) both in terms of
improved cell-based potency and a more suitable overall
proﬁle for clinical development as anti-HCV agents. A
library of 500 compounds was designed in solution
and these compounds were assessed for activity against
the puriﬁed DC55 NS5B enzyme (IC50) in the presence
of heterogenic template RNA. Inhibition of replication
of subgenomic HCV RNA was measured in HUH-7
cells. From this study, a number of actives were ob-
tained, of which (iv) was one of the most potent in the
NS5B cell-based assay, displaying an EC50 of 127 nM.
This compound also displayed encouraging pharmaco-
kinetics in rat and dog. The present research highlights
the potential of this structural series for the development
of novel anti-HCV agents.N
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(iii): NS5B IC50 = 26 nM (iv): NS5B EC50 = 127 nM2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
A comparison of two routes towards the synthesis of
tetramethylcyclopentadienes on a range of diﬀerent
polymer supports has been presented. It was found that
the direct displacement of the halide from halogen ter-
minated polymers furnished a cleaner product and in
fewer steps.3
Peptidotriazoles, unnatural oligomers with alternating
amide and triazole linkages, have been synthesised
eﬃciently on solid support. The key transformations
involve multiple cycles of 1,2,3-triazole formation, using
soluble Cu(I) catalyst and conditions that do not gener-
ate precipitate on solid support nor require exclusion of
oxygen.4
A facile, mild and rapid solid phase synthetic route free
of column chromatographic puriﬁcation to the synthesis
of soluble long-chain monodisperse oligo(1,4-phenyle-
neethynylene)s has been described.5
A new, convenient, eﬃcient and cost-eﬀective one-pot
solid supported synthesis of 2,4,6-triarylpyridines from
benzylideneacetophenones and urea, thiourea or their
derivatives, using Bi(III) nitrate–Al2O3 has been
described.6
2.2. Solution-phase synthesis
The reaction conditions and scope and limitations of the
preparation of 5-aminoindolizines starting from oxaz-
olo[3,2-a]pyridinium salts and diﬀerent amines has been
investigated in order to evaluate the utility for combina-
torial library construction.7
A reliable and convenient protocol for multiple compo-
nent reactions between 2-aminopyrimidine, aldehydes
and isonitriles suitable for combinatorial synthesis has
been described.8
A simple one-pot, solution phase method for the parallel
synthesis of carbamates from amines and alcohols has
been described. The high-yielding method does not
require support-bound reagents, extractions or resin
washing steps and should be broadly applicable to the
manual or automated generation of carbamate
libraries.9
2.3. Scaﬀolds for combinatorial libraries
No papers this month.
2.4. Solid-phase supported reagents
4-(N-Mesitylamino)polystyrene resin-bound penta-
ﬂuorobenzenesulphonate serves as extremely active
dehydration catalysts for the ester condensation reaction
of carboxylic acids with sterically demanding alcohols
and acid-sensitive alcohols and can be recycled more
than 10 times without a loss of activity.10
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ﬁeld resin, a reusable heterogeneous catalyst has been
obtained for the reaction of amines and thiols with
Michael acceptors.11
2.5. Novel resins, linkers and techniques
The reactivity of three polymer-bound cyclohexadienoic
acid active esters has been modiﬁed by complexation
with iron tricarbonyl in order to evaluate their potential
use as linker systems for solid phase chemistry.12
2.6. Library applications
A test library with three novel p38a inhibitory scaﬀolds
and a narrow set of substituents has been prepared, and
has generated p38a inhibitors with potent in vivo activ-
ity upon oral administration in animal models of rheu-
matoid arthritis.13
Four stereoisomeric hybrids of the polyketide natural
products callystatin A and leptomycin B have been
prepared by parallel synthetic routes involving chiral
allenylstannane methodology. Like their natural
counterparts, these hybrids exhibit nanomolar levels
of cytotoxicity toward HCT-116 human colon cancer
cells.14
Farnesyltransferase inhibitors identiﬁed from an
ECLiPS library were optimised using solution-phase
synthesis. X-ray crystallography of inhibited complexes
was used to identify substructures that coordinate to
the active site zinc, and the X-ray structures ultimately
used to guide the design of second-generation analogues
with FTase IC50s below 1.0 nM.
15
Fragment-based virtual library design and virtual
screening have been conducted against malic enzyme
(ME) homology model, and several scaﬀolds have been
identiﬁed as promising motifs to target ME’s NADP
binding site. One small focused library has been synthes-
ised and tested against ME, with several compounds
showing sub-micromolar inhibitory activity.16
A focused quinazolinone natural product-templated
library has been designed and synthesised, and com-
pounds were identiﬁed as antimitotic agents acting
through destabilisation of tubulin polymerisation.17
The SAR of a novel ligand for the a2d subunit of volt-
age-gated calcium channels, was rapidly explored using
a parallel solution-phase Sn2Ar coupling approach.
The library was evaluated in vitro and aﬀorded a series
of analogues with improved potencies.18
An improved method for the synthesis of benzamides
via parallel solution-phase chemistry has been pre-
sented, and the compounds evaluated for anticonvulsant
activity as well as evaluation as potential inhibitors of
phosphodiesterase type IV for use as antiasthmatics.19
To investigate one possible mechanism of action of the
cytotoxic activity of benzothiazoles, 2-(substituted-phenyl)benzothiazoles were evaluated for their ability
to inhibit topoisomerase II activities. Solid phase combi-
natorial method using trityl resin was employed and
benzothiazole derivatives with various substitution on
2 0-, 3 0-, or 4 0-position of phenyl group were obtained.20
A low molecular weight inhibitor of a-amylases based
on a linear peptidic scaﬀold has been designed de novo
through the use of combinatorial chemistry. The inhibi-
tory motif denoted PAMI (peptide amylase inhibitor)
was selected by using L-peptide libraries and was ﬁne-
tuned by the introduction of unnatural modiﬁcations.21References
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